Literature DB >> 2506806

Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding.

J H Yuk1, C H Nightingale, K R Sweeney, R Quintiliani, J T Lettieri, R W Frost.   

Abstract

The bioavailability of ciprofloxacin after its administration through a nasogastric (NG) feeding tube was studied in six healthy volunteers. Each subject received, on separate occasions, an intact 750-mg ciprofloxacin tablet, a crushed tablet as a suspension through an NG tube, and a crushed tablet as a suspension through an NG tube while receiving enteral feeding. No statistically significant differences were observed in the area under the curve, maximum concentration in serum, and time to peak concentration among these three modes of administration. These findings suggest that ciprofloxacin is well absorbed after administration via an NG tube (compared with an orally administered intact tablet) even in the presence of enteral feeding.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506806      PMCID: PMC176075          DOI: 10.1128/AAC.33.7.1118

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Reduced enteral absorption of ciprofloxacin in the presence of antacids.

Authors:  G Höffken; K Borner; P D Glatzel; P Koeppe; H Lode
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

2.  Absolute oral bioavailability of ciprofloxacin.

Authors:  G L Drusano; H C Standiford; K Plaisance; A Forrest; J Leslie; J Caldwell
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Effect of dose size on bioavailability of ciprofloxacin.

Authors:  K I Plaisance; G L Drusano; A Forrest; C I Bustamante; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Unexpected mobilisation of lead during cisplatin chemotherapy.

Authors:  A M el-Sharkawi; W D Morgan; S Cobbold; M B Jaib; C J Evans; L J Somervaille; D R Chettle; M C Scott
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

5.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

6.  Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

Authors:  B Ledergerber; J D Bettex; B Joos; M Flepp; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

7.  Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.

Authors:  T Bergan; S B Thorsteinsson; R Solberg; L Bjornskau; I M Kolstad; S Johnsen
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

8.  Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.

Authors:  T A Tartaglione; A C Raffalovich; W J Poynor; A Espinel-Ingroff; T M Kerkering
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

  8 in total
  11 in total

Review 1.  Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Authors:  A Aminimanizani; P Beringer; R Jelliffe
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.

Authors:  M H Chandler; S M Toler; R P Rapp; R R Muder; J A Korvick
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

3.  Clinical Equivalency of Ciprofloxacin 750 mg Enterally and 400 mg Intravenously for Patients Receiving Enteral Feeding: Systematic Review.

Authors:  Donna Chui; Lily Cheng; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2009-03

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.

Authors:  B A Mueller; D G Brierton; S R Abel; L Bowman
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

Authors:  D P Healy; M C Brodbeck; C E Clendening
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 7.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

8.  Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.

Authors:  Olaf Burkhardt; Heino Stass; Uwe Thuss; Klaus Borner; Tobias Welte
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 9.  Pharmacokinetics of quinolones: newer aspects.

Authors:  J S Wolfson; D C Hooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 10.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.